| Year |
Citation |
Score |
| 2023 |
He F, Tay AHM, Calandigary A, Malki E, Suzuki S, Liu T, Wang Q, Fernández-Moro C, Kaisso M, Olofsson-Sahl P, Melssen M, Sze SK, Björnstedt M, Löhr MJ, Karlsson MCI, ... ... Sarhan D, et al. FPR2 shapes an immune-excluded pancreatic tumor microenvironment and drives T-cell exhaustion in a sex-dependent manner. Cancer Research. PMID 36919330 DOI: 10.1158/0008-5472.CAN-22-2932 |
0.437 |
|
| 2022 |
Sarhan D, Eisinger S, He F, Bergsland M, Pelicano C, Driescher C, Westberg K, Benitez II, Humoud R, Palano G, Li S, Carannante V, Muhr J, Önfelt B, Schlisio S, et al. Targeting myeloid suppressive cells revives cytotoxic anti-tumor responses in pancreatic cancer. Iscience. 25: 105317. PMID 36310582 DOI: 10.1016/j.isci.2022.105317 |
0.581 |
|
| 2022 |
He F, Furones AR, Landegren N, Fuxe J, Sarhan D. Sex dimorphism in the tumor microenvironment - From bench to bedside and back. Seminars in Cancer Biology. PMID 35278635 DOI: 10.1016/j.semcancer.2022.03.007 |
0.329 |
|
| 2021 |
Gultekin O, Gonzalez-Molina J, Hardell E, Moyano-Galceran L, Mitsios N, Mulder J, Kokaraki G, Isaksson A, Sarhan D, Lehti K, Carlson JW. FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation. Npj Precision Oncology. 5: 97. PMID 34799669 DOI: 10.1038/s41698-021-00236-6 |
0.438 |
|
| 2021 |
Razaghi A, Poorebrahim M, Sarhan D, Björnstedt M. Selenium stimulates the antitumour immunity: Insights to future research. European Journal of Cancer (Oxford, England : 1990). 155: 256-267. PMID 34392068 DOI: 10.1016/j.ejca.2021.07.013 |
0.313 |
|
| 2021 |
Chen Z, Yang Y, Neo SY, Shi H, Chen Y, Wagner AK, Larsson K, Tong L, Jakobsson PJ, Alici E, Wu J, Cao Y, Wang K, Liu LL, Mao Y, ... Sarhan D, et al. Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25 /CD54 NK cells. Embo Reports. e51329. PMID 33480074 DOI: 10.15252/embr.202051329 |
0.771 |
|
| 2020 |
La Fleur L, Botling J, He F, Pelicano C, Zhou C, He C, Palano G, Mezheyeuski A, Micke P, Ravetch JV, Karlsson MCI, Sarhan D. Targeting MARCO and IL-37R on immunosuppressive macrophages in lung cancer blocks regulatory T cells and supports cytotoxic lymphocyte function. Cancer Research. PMID 33293426 DOI: 10.1158/0008-5472.CAN-20-1885 |
0.588 |
|
| 2020 |
Eisinger S, Sarhan D, Boura VF, Ibarlucea-Benitez I, Tyystjärvi S, Oliynyk G, Arsenian-Henriksson M, Lane D, Wikström SL, Kiessling R, Virgilio T, Gonzalez SF, Kaczynska D, Kanatani S, Daskalaki E, et al. Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 33229588 DOI: 10.1073/pnas.2015343117 |
0.522 |
|
| 2020 |
Sarhan D, Wang J, Sunil Arvindam U, Hallstrom C, Verneris MR, Grzywacz B, Warlick E, Blazar BR, Miller JS. Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function. Jci Insight. PMID 32045384 DOI: 10.1172/Jci.Insight.130155 |
0.441 |
|
| 2020 |
Fleur LL, Botling J, He F, Pelicano C, Palano G, Mezheyeuski A, Micke P, Ravetch J, Karlsson M, Sarhan D. 720 Targeting MARCO and IL-37R on anti-inflammatory macrophages in lung cancer blocks regulatory T cells and shift balance to support cytotoxic lymphocyte function Journal For Immunotherapy of Cancer. 8: A762-A762. DOI: 10.1136/jitc-2020-sitc2020.0720 |
0.575 |
|
| 2019 |
Sarhan D, Miller JS. Assessing Canonical and Adaptive Natural Killer Cell Function in Suppression Assays In Vitro. Methods in Molecular Biology (Clifton, N.J.). 1913: 153-166. PMID 30666605 DOI: 10.1007/978-1-4939-8979-9_11 |
0.616 |
|
| 2018 |
Sarhan D, Brandt L, Felices M, Guldevall K, Lenvik T, Hinderlie P, Curtsinger J, Warlick E, Spellman SR, Blazar BR, Weisdorf DJ, Cooley S, Vallera DA, Önfelt B, Miller JS. 161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS. Blood Advances. 2: 1459-1469. PMID 29941459 DOI: 10.1182/Bloodadvances.2017012369 |
0.618 |
|
| 2018 |
Sarhan D, Hippen KL, Lemire A, Hying S, Luo X, Lenvik T, Curtsinger J, Davis Z, Zhang B, Cooley S, Cichocki F, Blazar BR, Miller JS. Adaptive NK cells resist regulatory T cell suppression driven by IL-37. Cancer Immunology Research. PMID 29784636 DOI: 10.1158/2326-6066.Cir-17-0498 |
0.658 |
|
| 2018 |
de Witte MA, Sarhan D, Davis Z, Felices M, Vallera DA, Hinderlie P, Curtsinger J, Cooley S, Wagner J, Kuball J, Miller JS. Early Reconstitution of NK and Γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29505821 DOI: 10.1016/J.Bbmt.2018.02.023 |
0.596 |
|
| 2017 |
Bachanova V, Sarhan D, DeFor TE, Cooley S, Panoskaltsis-Mortari A, Blazar BR, Curtsinger JM, Burns L, Weisdorf DJ, Miller JS. Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells. Cancer Immunology, Immunotherapy : Cii. PMID 29218366 DOI: 10.1007/S00262-017-2100-1 |
0.5 |
|
| 2017 |
Sarhan D, Leijonhufvud C, Murray S, Witt K, Seitz C, Wallerius M, Xie H, Ullén A, Harmenberg U, Lidbrink E, Rolny C, Andersson J, Lundqvist A. Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer. Oncoimmunology. 6: e1338238. PMID 28920001 DOI: 10.1080/2162402X.2017.1338238 |
0.754 |
|
| 2017 |
Cichocki F, Valamehr B, Bjordahl R, Zhang B, Rezner B, Rogers P, Gaidarova S, Moreno SK, Tuininga K, Dougherty P, McCullar V, Howard P, Sarhan D, Taras E, Schlums H, et al. GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity. Cancer Research. PMID 28790065 DOI: 10.1158/0008-5472.Can-17-0799 |
0.626 |
|
| 2017 |
Lövgren T, Sarhan D, Truxová I, Choudhary B, Maas R, Melief J, Nyström M, Edbäck U, Vermeij R, Scurti G, Nishimura M, Masucci G, Karlsson-Parra A, Lundqvist A, Adamson L, et al. Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists. Cancer Immunology, Immunotherapy : Cii. PMID 28601925 DOI: 10.1007/S00262-017-2029-4 |
0.655 |
|
| 2017 |
Cichocki F, Valamehr B, Bjordahl R, Zhang B, Sarhan D, Cooley S, Blazar B, Rezner B, Rogers P, Green C, Abbot S, Shoemaker D, Wolchko S, Miller JS. Abstract 3752: FATE-NK100: A novel NK cell-mediated cancer therapy Cancer Research. 77: 3752-3752. DOI: 10.1158/1538-7445.Am2017-3752 |
0.582 |
|
| 2017 |
Bachanova V, Sarhan D, Defor T, Cooley S, Panoskaltsis-Mortari A. LOW LEVELS OF IMMUNO-SUPPRESSOR CELLS PROMOTE RESPONSES TO A HAPLOIDENTICAL NATURAL KILLER CELL THERAPY AND INDUCE REMISSIONS IN NON-HODGKIN LYMPHOMA Hematological Oncology. 35: 261-62. DOI: 10.1002/hon.2438_130 |
0.358 |
|
| 2016 |
Luu TT, Ganesan S, Wagner AK, Sarhan D, Meinke S, Garbi N, Hämmerling G, Alici E, Kärre K, Chambers BJ, Höglund P, Kadri N. Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells. Scientific Reports. 6: 37996. PMID 27905484 DOI: 10.1038/Srep37996 |
0.571 |
|
| 2016 |
Sarhan D, Cichocki F, Zhang B, Yingst A, Spellman SR, Cooley S, Verneris MR, Blazar BR, Miller JS. Adaptive NK cells with low TIGIT expression are inherently resistant to myeloid-derived suppressor cells. Cancer Research. PMID 27503932 DOI: 10.1158/0008-5472.Can-16-0839 |
0.622 |
|
| 2016 |
Felices M, Sarhan D, Brandt L, Guldevall K, McElmurry R, Lenvik A, Chu S, Tolar J, Taras E, Spellman SR, Warlick ED, Verneris MR, Cooley S, Weisdorf D, Blazar BR, et al. CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics Blood. 128: 4291-4291. DOI: 10.1182/Blood.V128.22.4291.4291 |
0.459 |
|
| 2016 |
Bachanova V, Sarhan D, DeFor TE, Cooley S, Panoskaltsis-Mortari A, Verneris MR, Blazar BR, Curtsinger J, Burns LJ, Weisdorf DJ, Miller JS. Haploidentical Natural Killer Cell Infusion Induces Remission in Non-Hodgkin Lymphoma and Overcomes Resistance to Rituximab Blood. 128: 3030-3030. DOI: 10.1182/Blood.V128.22.3030.3030 |
0.517 |
|
| 2016 |
Cichocki F, Valamehr B, Sarhan D, Zhang B, Cooley S, Verneris MR, Blazar BR, Bjordahl R, Rezner B, Rogers P, Green C, McKenna DH, Shoemaker D, Wolchko S, Miller JS. Development and Scale-up of a Novel GMP Method for Enrichment and Expansion of Terminally Differentiated Adaptive Natural Killer Cells (FATE-NK100) with Enhanced Anti-Tumor Function Blood. 128: 1225-1225. DOI: 10.1182/Blood.V128.22.1225.1225 |
0.596 |
|
| 2016 |
Adamson L, Sarhan D, Choudhary B, Melief J, Nyström M, Edbäck U, Vermeij R, Scurti G, Nishimura M, Lundqvist A, Kiessling R, Lövgren T. Abstract B071: Enhanced IL-12 production and T cell stimulation ability by dendritic cells matured in presence of GMP-grade Toll-like receptor ligands and IFN-γ Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B071 |
0.657 |
|
| 2015 |
Dahlberg CI, Sarhan D, Chrobok M, Duru AD, Alici E. Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity. Frontiers in Immunology. 6: 605. PMID 26648934 DOI: 10.3389/fimmu.2015.00605 |
0.589 |
|
| 2015 |
Sarhan D, Palma M, Mao Y, Adamson L, Kiessling R, Mellstedt H, Österborg A, Lundqvist A. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β. European Journal of Immunology. 45: 1783-93. PMID 25773885 DOI: 10.1002/Eji.201444885 |
0.696 |
|
| 2014 |
Sarhan D, D'Arcy P, Lundqvist A. Regulation of TRAIL-receptor expression by the ubiquitin-proteasome system. International Journal of Molecular Sciences. 15: 18557-73. PMID 25318057 DOI: 10.3390/Ijms151018557 |
0.653 |
|
| 2014 |
Mao Y, Sarhan D, Steven A, Seliger B, Kiessling R, Lundqvist A. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4096-106. PMID 24907113 DOI: 10.1158/1078-0432.Ccr-14-0635 |
0.717 |
|
| 2014 |
Mao Y, Sarhan D, Poschke I, Lundqvist A, Kiessling R. Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P224 |
0.771 |
|
| 2014 |
Sarhan D, Palma M, Mao Y, Adamson L, Kiessling R, Mellstedt H, Österborg A, Lundqvist A. Regulation of Natural Killer Cell Responses By Dendritic Cells Via Lymphotoxin-Alpha, Interleukin-12, and Tumor Growth Factor-Beta Blood. 124: 4140-4140. DOI: 10.1182/Blood.V124.21.4140.4140 |
0.694 |
|
| 2013 |
Sarhan D, Wennerberg E, D'Arcy P, Gurajada D, Linder S, Lundqvist A. A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells. Cancer Immunology, Immunotherapy : Cii. 62: 1359-68. PMID 23689729 DOI: 10.1007/S00262-013-1439-1 |
0.789 |
|
| 2013 |
Wennerberg E, Sarhan D, Carlsten M, Kaminskyy VO, D'Arcy P, Zhivotovsky B, Childs R, Lundqvist A. Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling. International Journal of Cancer. 133: 1643-52. PMID 23504627 DOI: 10.1002/Ijc.28163 |
0.795 |
|
| 2013 |
Sarhan D, D'Arcy P, Wennerberg E, Lidén M, Hu J, Winqvist O, Rolny C, Lundqvist A. Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ. European Journal of Immunology. 43: 249-57. PMID 22996291 DOI: 10.1002/Eji.201242735 |
0.799 |
|
| 2012 |
Kiessling R, Okita R, Mougiakakos D, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kono K. Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells. Oncoimmunology. 1: 1200-1201. PMID 23170279 DOI: 10.4161/Onci.20685 |
0.736 |
|
| 2012 |
Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kiessling R. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines. Journal of Immunology (Baltimore, Md. : 1950). 188: 2136-45. PMID 22301547 DOI: 10.4049/Jimmunol.1102237 |
0.739 |
|
| Show low-probability matches. |